BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 12, 2018
View Archived Issues
Exosomes deliver no-NO arginase in diabetes
Read More
Novel TZD CMHX-008 maintains insulin sensitization with minor effects on weight gain and bone loss
Read More
Feeding findings may hold key to appetite control
Read More
Achillion initiates first-in-human study of ACH-5548
Read More
Researchers develop a rat model of diabetic cardiomyopathy for cardiovascular evaluation
Read More
FDA clears IND for Adagene's phase I study of ADG-106
Read More
Investigating isoflavonoids for the potential treatment of obesity and diabetes
Read More
[225Ac]DOTA-PEG7-5B1 as pretargeted radioimmunotherapy for pancreatic ductal adenocarcinoma
Read More
BioSight receives clearance to initiate phase IIb study of BST-236 in AML
Read More
Ovid Therapeutics initiates phase II ROCKET trial of OV-101 in fragile X syndrome
Read More
Tegsedi approved in the E.U. for the treatment of hATTR
Read More
First patient dosed in phase II study of CV-301 plus nivolumab in metastatic colorectal cancer
Read More
Recursion set to begin phase I study of AI/ML-based drug candidate, REC-994
Read More
Advaxis withdraws conditional MAA for axalimogene filolisbac, advances ADXS-HOT program
Read More
Argenx presents phase II data for ARGX-113 in myasthenia gravis
Read More
OG-716, a lantibiotic that is active against Clostridium difficile infections
Read More
Amgen describes new beta-secretase inhibitors
Read More
National Center for Global Health and Medicine, Kumamoto University and Yamasa patent antivirals
Read More
Galapagos, AbbVie discover CFTR modulators
Read More
Pivotal study of KP-415 in children with ADHD meets primary efficacy endpoint
Read More
New phase II trial explores voclosporin ophthalmic solution for dry eye syndrome
Read More
Genmab and Immatics partner on next-generation bispecific cancer immunotherapies
Read More
New phase III trial investigates etripamil for termination of spontaneous PSVT
Read More
TAS-114 combined with S-1 shows preliminary efficacy in pretreated advanced gastric cancer patients
Read More
Japanese researchers present phase II data on TAS-205 in patients with DMD
Read More
Phase III maintenance trial of Ninlaro in multiple myeloma meets primary endpoint
Read More
Phase III study of Imbruvica in treatment-naive DLBCL misses primary endpoint
Read More